Literature DB >> 16646777

Pre-validation and inference in microarrays.

Robert J Tibshirani1, Brad Efron.   

Abstract

In microarray studies, an important problem is to compare a predictor of disease outcome derived from gene expression levels to standard clinical predictors. Comparing them on the same dataset that was used to derive the microarray predictor can lead to results strongly biased in favor of the microarray predictor. We propose a new technique called "pre-validation'' for making a fairer comparison between the two sets of predictors. We study the method analytically and explore its application in a recent study on breast cancer.

Entities:  

Year:  2002        PMID: 16646777     DOI: 10.2202/1544-6115.1000

Source DB:  PubMed          Journal:  Stat Appl Genet Mol Biol        ISSN: 1544-6115


  53 in total

1.  Melanoma MicroRNA signature predicts post-recurrence survival.

Authors:  Miguel F Segura; Ilana Belitskaya-Lévy; Amy E Rose; Jan Zakrzewski; Avital Gaziel; Douglas Hanniford; Farbod Darvishian; Russell S Berman; Richard L Shapiro; Anna C Pavlick; Iman Osman; Eva Hernando
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

2.  Signatures of cardioembolic and large-vessel ischemic stroke.

Authors:  Glen C Jickling; Huichun Xu; Boryana Stamova; Bradley P Ander; Xinhua Zhan; Yingfang Tian; Dazhi Liu; Renée J Turner; Matthew Mesias; Piero Verro; Jane Khoury; Edward C Jauch; Arthur Pancioli; Joseph P Broderick; Frank R Sharp
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

3.  Patient subgroup identification for clinical drug development.

Authors:  Xin Huang; Yan Sun; Paul Trow; Saptarshi Chatterjee; Arunava Chakravartty; Lu Tian; Viswanath Devanarayan
Journal:  Stat Med       Date:  2017-02-01       Impact factor: 2.373

4.  Pathway-structured predictive modeling for multi-level drug response in multiple myeloma.

Authors:  Xinyan Zhang; Bingzong Li; Huiying Han; Sha Song; Hongxia Xu; Zixuan Yi; Yating Hong; Wenzhuo Zhuang; Nengjun Yi
Journal:  Bioinformatics       Date:  2018-11-01       Impact factor: 6.937

5.  Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.

Authors:  Xinyan Zhang; Yan Li; Tomi Akinyemiju; Akinyemi I Ojesina; Phillip Buckhaults; Nianjun Liu; Bo Xu; Nengjun Yi
Journal:  Genetics       Date:  2016-11-09       Impact factor: 4.562

6.  Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts.

Authors:  D S Cross; C A McCarty; E Hytopoulos; M Beggs; N Nolan; D S Harrington; T Hastie; R Tibshirani; R P Tracy; B M Psaty; R McClelland; P S Tsao; T Quertermous
Journal:  Curr Med Res Opin       Date:  2012-11       Impact factor: 2.580

7.  Testing the additional predictive value of high-dimensional molecular data.

Authors:  Anne-Laure Boulesteix; Torsten Hothorn
Journal:  BMC Bioinformatics       Date:  2010-02-08       Impact factor: 3.169

8.  Genome response to tissue plasminogen activator in experimental ischemic stroke.

Authors:  Glen C Jickling; Xinhua Zhan; Bradley P Ander; Renée J Turner; Boryana Stamova; Huichun Xu; Yingfang Tian; Dazhi Liu; Ryan R Davis; Paul A Lapchak; Frank R Sharp
Journal:  BMC Genomics       Date:  2010-04-21       Impact factor: 3.969

9.  Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis.

Authors:  R Fernández-Ramires; X Solé; L De Cecco; G Llort; A Cazorla; N Bonifaci; M J Garcia; T Caldés; I Blanco; M Gariboldi; M A Pierotti; M A Pujana; J Benítez; A Osorio
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

10.  Quantitative comparison of microarray experiments with published leukemia related gene expression signatures.

Authors:  Hans-Ulrich Klein; Christian Ruckert; Alexander Kohlmann; Lars Bullinger; Christian Thiede; Torsten Haferlach; Martin Dugas
Journal:  BMC Bioinformatics       Date:  2009-12-15       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.